M&A PAIR TRADING: THE POPOLARI BANKS CASE

This week, we are proud to publish an in-deep analysis on the Italian Popolari banks situation, one of the most discussed topics since the announcement of the AQR done by the ECB. Thanks to the recent rumors of an Italian decree, which changes the voting powers’ structure of the above mentioned banks, stocks have sky […]

GREXIT: A Recap, A Trade

It has been a tough couple of weeks for the Euro area and what seemed like a major Euro breakdown turned -temporarily- into a much more stable situation this week. But let us go back in time a little, when Grexit was more likely. Up to just a couple of weeks ago, the debt burden […]

MARKET RECAP 28|02|2015

US The biggest event for US markets this week was certainly Fed Chairwoman Janet Yellen’s testimony before the Senate Banking Committee on Tuesday. Indicating that if the US economy improved further, she stated that the central bank could change its language and abandon its “patient” stance (which means not to make a move for at […]

Iberdrola responds to Spanish austerity measures: UIL acquired in a $3bn deal

UIL Holdings Corp.; market cap (as of 27/02/15): US$2.86bn Iberdrola SA; market cap (as of 27/02/15): US$43.5bn   Introduction  On February 26, Iberdrola SA, Spain’s largest electricity company, agreed to buy UIL Holdings Corp. in a deal valued at about US$3bn in cash and shares. With the acquisition, Iberdrola plans on merging its American subsidiary […]

Valeant, the serial pharma dealmaker cuts again

Valeant Pharmaceuticals International, Inc.; market cap (as of 26/02/2015): US$76.68bn Salix Pharmaceuticals, Ltd.; market cap (as of 26/02/2015): US$10.07bn     Introduction The pharmaceutical industry has undergone an intense period of consolidation in the past 18 months which is far from over as the big players take advantage of the cheap credit to acquire the […]

HP looking to patch its holes with Aruba Networks

Hewlett-Packard Company; Market Cap (as of 27/02/2015): US$63.86bn Aruba Networks Inc.; Market Cap (as of 27/02/2015): US$2.72bn   Introduction Hewlett-Packard (HP) CEO Meg Whitman has announced on Tuesday that the company is in the position to make acquisitions with media reporting on Wednesday that the company is exploring the possibility to acquire Aruba Networks. Although […]

MARKET RECAP 21/02/2015

US  Big news has struck the US economy this week and in particular the ones oil-related has had a strong effect on the market. The US economy has been once again the main driver of the fall in oil prices this week as the country’s stockpiles of crude last week increased by 7.7 million to […]

WTI and Brent: So Similar, So Different

As everyone knows, a commodity is a raw material – fungible by definition – that is supposed to trade in any market of the world for the same price. But when it comes to crude oil, things are not as simple. As it is widely known, the two main qualities of crude are represented by […]

Samsung enters the race for mobile payments with LoopPay

Samsung Electronics Co. Ltd.; market cap (as of 20/02/2015): $184.12bn Sector leadership and the acquisition The push to eradicate bulky wallets stuffed with cards seems to be picking up some steam. Samsung’s recent acquisition of mobile wallet startup LoopPay is seen as a strong sign of intensifying competition in the mobile payments sector. The transaction, […]

BT is Back with a Bang: $19bn deal with EE form UK’s quad-play biggest operator

BT Group plc.; market cap (as of 20/02/2015): $54.66bn Introduction On February 5th, 2015, BT agreed to acquire the British network operator EE from Deutsche Telekom and Orange in a £12.5bn (US$19bn) deal to form the leading telecommunication provider in the UK. Companies’ Overview British Telecom Group, is the world’s oldest multinational telecommunications company headquartered […]

Pfizer sets sail for a new (nearer) shore: Hospira

Pfizer Inc.; market cap (as of 20/02/2015): US$217.75bn Hospira Inc.; market cap (as of 20/02/2015): US$14.97bn Introduction On February 5th, 2014, pharmaceutical behemoth Pfizer signed with Hospira, the world’s leading provider of injectable drugs and biosimilars, a definitive merger agreement which consists of the fully acquisition of Hospira for US$90 per share, thus valuing the […]